Show simple item record

dc.creatorXU, KEMAN
dc.creatorKhan, Mohsin
dc.creatorYu, Jun
dc.creatorSnyder, Nathaniel
dc.creatorWu, Sheng
dc.creatorVazquez-Padron, Roberto I.
dc.creatorWang, Hong
dc.creatorYang, Xiaofeng
dc.date.accessioned2023-01-06T17:20:53Z
dc.date.available2023-01-06T17:20:53Z
dc.date.issued2022-07-26
dc.identifier.citationXu K, Khan M, Yu J, Snyder NW, Wu S, Vazquez-Padron RI, Wang H and Yang X (2022) Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics. Front. Cardiovasc. Med. 9:981544. doi: 10.3389/fcvm.2022.981544
dc.identifier.issn2297-055X
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/8239
dc.identifier.urihttp://hdl.handle.net/20.500.12613/8268
dc.description.abstractWith the effort and support of the authors, editorial office, and editorial team, the Frontiers in Cardiovascular Medicine, Cardiovascular Therapeutics Section-Research Topic “Insights in Cardiovascular Therapeutics: 2021” has achieved great success and is attracting interest from the cardiovascular community. Here, we spotlight 12 studies published in our section that related to cell death and cardiovascular injuries, as well as some recent advances in the field that have tremendous potential in cardiovascular therapy. In addition, these highlights may serve as the foundation for some new developments in our Cardiovascular Therapeutics areas. In 2022, we will keep working to create a fantastic platform for cardiologists, translational cardiovascular scientists, and cardiovascular pharmacological scientists to share new results and data in clinical cardiology and translational cardiovascular therapeutics.
dc.format.extent5 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofFaculty/Researcher Works
dc.relation.haspartFrontiers in Cardiovascular Medicine, Vol. 9
dc.relation.isreferencedbyFrontiers Media
dc.rightsAttribution CC BY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectCell death
dc.subjectCardiovascular injuries
dc.subjectNovel targets
dc.subjectCardiovascular therapeutics
dc.subjectInflammation
dc.titleEditorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
dc.typeText
dc.type.genreArticle (Other)
dc.contributor.groupCardiovascular Research Center (Temple University)
dc.contributor.groupCenters for Metabolic Disease Research (Temple University)
dc.description.departmentCardiovascular Sciences
dc.description.departmentBiomedical Education and Data Sciences
dc.relation.doihttps://doi.org/10.3389/fcvm.2022.981544
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeLewis Katz School of Medicine
dc.creator.orcidXu|0000-0002-0816-1760
dc.creator.orcidKhan|0000-0001-7007-1048
dc.creator.orcidYu|0000-0003-4530-2179
dc.creator.orcidSnyder|0000-0001-5643-8747
dc.creator.orcidWang|0000-0001-6258-4070
dc.creator.orcidYang|0000-0002-6854-6195
dc.temple.creatorXu, Keman
dc.temple.creatorKhan, Mohsin
dc.temple.creatorYu, Jun
dc.temple.creatorSnyder, Nathaniel W.
dc.temple.creatorWu, Sheng
dc.temple.creatorWang, Hong
dc.temple.creatorYang, Xiaofeng
refterms.dateFOA2023-01-06T17:20:53Z


Files in this item

Thumbnail
Name:
XuEtAl-Article-2022.pdf
Size:
128.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY